糖尿病患者腹腔镜手术术前指尖触觉功能与术后谵妄的关系:一项单中心、前瞻性队列研究

注册号:

Registration number:

ChiCTR2500109836 

最近更新日期:

Date of Last Refreshed on:

2025-09-25 15:53:45 

注册时间:

Date of Registration:

2025-09-25 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

糖尿病患者腹腔镜手术术前指尖触觉功能与术后谵妄的关系:一项单中心、前瞻性队列研究

Public title:

The relationship between preoperative fingertip tactile function and postoperative delirium in patients with diabetes undergoing laparoscopic surgery: a single-center, prospective cohort study

注册题目简写:

English Acronym:

研究课题的正式科学名称:

糖尿病患者腹腔镜手术术前指尖触觉功能与术后谵妄的关系:一项单中心、前瞻性队列研究

Scientific title:

the relationship between preoperative fingertip tactile function and postoperative delirium in patients with diabetes undergoing laparoscopic surgery: a single-center, prospective cohort study

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈明浩 

研究负责人:

陈明浩 

Applicant:

Minghao Chen 

Study leader:

Minghao Chen 

申请注册联系人电话:

Applicant telephone:

+86 631 5287613

研究负责人电话:

Study leader's
telephone:

+86 631 5287613

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

89661956@qq.com

研究负责人电子邮件:

Study leader's E-mail:

89661956@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东省威海市环翠区和平路70号

研究负责人通讯地址:

山东省威海市环翠区和平路70号

Applicant address:

No. 70, Heping Road, Huancui District, Weihai City, Shandong Province

Study leader's address:

No. 70, Heping Road, Huancui District, Weihai City, Shandong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

威海市立医院麻醉科

Applicant's institution:

Weihai Municipal Hospital

研究负责人所在单位:

威海市立医院

Affiliation of the Leader:

Weihai Municipal Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025101

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

威海市立医院伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Weihai Municipal Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-09-18 00:00:00

伦理委员会联系人:

王晓英

Contact Name of the ethic committee:

Xiaoying Wang

伦理委员会联系地址:

山东省威海市环翠区和平路70号

Contact Address of the ethic committee:

No. 70, Heping Road, Huancui District, Weihai City, Shandong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 631 5287693

伦理委员会联系人邮箱:

Contact email of the ethic committee:

wxysdwh@163.com

研究实施负责(组长)单位:

威海市立医院

Primary sponsor:

Weihai Municipal Hospital

研究实施负责(组长)单位地址:

威海市环翠区和平路70号

Primary sponsor's address:

No. 70, Heping Road, Huancui District, Weihai City, Shandong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东省

市(区县):

Country:

China

Province:

Shandong

City:

单位(医院):

威海市立医院

具体地址:

威海市环翠区和平路70号

Institution
hospital:

Weihai Municipal Hospital

Address:

No. 70, Heping Road, Huancui District, Weihai City, Shandong Province

经费或物资来源:

山东省首批医药卫生重点学科建设项目

Source(s) of funding:

Key Discipline Construction Project of Medicine and Health in Shandong Province

研究疾病:

术后谵妄  

Target disease:

Postoperative delirium

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

接受腹腔镜手术的糖尿病患者术前指尖触觉功能与术后谵妄之间的关系。  

Objectives of Study:

The relationship between preoperative fingertip tactile function and postoperative delirium in diabetic patients undergoing laparoscopic surgery.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1、听力障碍者、无法进行有效沟通者或者有语言能力障碍者; 2、合并精神疾病、长期服用抗精神药物、抗抑郁药物滥用者; 3、既往脑出血、心梗等严重心脑血管疾病,合并痴呆、阿尔茨海默症、癫痫、帕金森等合并神经系统疾病; 4、伴有严重的全身性疾病,如严重的心脏病、重度慢性阻塞性肺疾病、肾衰竭、肝衰竭等合并其他系统重度疾病者。

Exclusion criteria:

1. Individuals with hearing impairments, those unable to communicate effectively, or those with speech disabilities; 2. Those with co-occurring mental illnesses, long-term use of antipsychotic medications, or those who abuse antidepressants; 3. Those with a history of severe cardiovascular diseases such as cerebral hemorrhage or myocardial infarction, combined with dementia, Alzheimer's disease, epilepsy, Parkinson's disease, or other neurological disorders; 4. Those with severe systemic diseases, such as severe heart disease, stage IV chronic obstructive pulmonary disease (COPD), renal failure, liver failure, and other severe systemic conditions.

研究实施时间:

Study execute time:

From 2025-11-30 00:00:00 To 2026-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-11-30 00:00:00 To 2026-12-31 00:00:00

干预措施:

Interventions:

组别:

POD组

样本量:

33

Group:

POD group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

非POD组

样本量:

106

Group:

Non-POD group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东省 

市(区县):

 

Country:

China

Province:

Shandong

City:

单位(医院):

威海市立医院 

单位级别:

三级甲等 

Institution
hospital:

Weihai Municipal Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后谵妄

指标类型:

主要指标

Outcome:

Postoperative delirium

Type:

Primary indicator

测量时间点:

术后1~3天

测量方法:

Measure time point of outcome:

1 to 3 days after surgery

Measure method:

指标中文名:

指尖触觉功能

指标类型:

次要指标

Outcome:

Fingertip tactile function

Type:

Secondary indicator

测量时间点:

术前1天

测量方法:

Measure time point of outcome:

fingertip tactile function

Measure method:

指标中文名:

术后住院天数

指标类型:

次要指标

Outcome:

Postoperative hospitalization days

Type:

Secondary indicator

测量时间点:

出院时间

测量方法:

Measure time point of outcome:

discharge

Measure method:

指标中文名:

PACU停留时间

指标类型:

次要指标

Outcome:

PACU stay time

Type:

Secondary indicator

测量时间点:

术后

测量方法:

Measure time point of outcome:

postoperation

Measure method:

指标中文名:

术后疼痛NRS评分

指标类型:

次要指标

Outcome:

Postoperative pain NRS score

Type:

Secondary indicator

测量时间点:

术后1天

测量方法:

Measure time point of outcome:

1 day after surgery

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2025-09-25 15:53:34